Park H, Jin Jung H, Soo Park H, Kim H, Park Y, Chun P
Molecules. 2025; 30(3).
PMID: 39942621
PMC: 11820736.
DOI: 10.3390/molecules30030517.
Saha S, Hemal M, Eidmum M, Mridha M
Healthc Technol Lett. 2025; 12(1):e12120.
PMID: 39816700
PMC: 11733311.
DOI: 10.1049/htl2.12120.
Koronowicz A, Krawczyk K, Such A, Piasna-Slupecka E, Drozdowska M, Leszczynska T
Nutrients. 2025; 16(24.
PMID: 39770908
PMC: 11679902.
DOI: 10.3390/nu16244287.
Wang X, Li Z, Xu J, Wang J, Li Y, Li Q
Clin Cosmet Investig Dermatol. 2024; 17:2733-2746.
PMID: 39629045
PMC: 11614586.
DOI: 10.2147/CCID.S477870.
Zanre V, Bellinato F, Cardile A, Passarini C, Di Bella S, Menegazzi M
Int J Mol Sci. 2024; 25(22).
PMID: 39596009
PMC: 11593403.
DOI: 10.3390/ijms252211939.
The multifaceted anticancer potential of luteolin: involvement of NF-κB, AMPK/mTOR, PI3K/Akt, MAPK, and Wnt/β-catenin pathways.
Singh D, Shukla G
Inflammopharmacology. 2024; 33(2):505-525.
PMID: 39543054
DOI: 10.1007/s10787-024-01596-8.
Hybrid Homodimeric Prodrug Nanoassemblies for Low-Toxicity and Synergistic Chemophotodynamic Therapy of Melanoma.
Xu P, Meng F, Wan J, Zhu H, Fang S, Wang H
Biomater Res. 2024; 28:0101.
PMID: 39492977
PMC: 11529783.
DOI: 10.34133/bmr.0101.
Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?.
Anvar M, Rashidan K, Arsam N, Rasouli-Saravani A, Yadegari H, Ahmadi A
Cancer Cell Int. 2024; 24(1):355.
PMID: 39465401
PMC: 11514949.
DOI: 10.1186/s12935-024-03525-9.
Melanoma genomics - will we go beyond BRAF in clinics?.
Mirek J, Bal W, Olbryt M
J Cancer Res Clin Oncol. 2024; 150(9):433.
PMID: 39340537
PMC: 11438618.
DOI: 10.1007/s00432-024-05957-2.
Leveraging the Photofunctions of Transition Metal Complexes for the Design of Innovative Phototherapeutics.
Lee L, Lo K
Small Methods. 2024; 8(11):e2400563.
PMID: 39319499
PMC: 11579581.
DOI: 10.1002/smtd.202400563.
An iron-based metal-organic framework nanoplatform for enhanced ferroptosis and oridonin delivery as a comprehensive antitumor strategy.
Cai M, Fu T, Zhu R, Hu P, Kong J, Liao S
Acta Pharm Sin B. 2024; 14(9):4073-4086.
PMID: 39309488
PMC: 11413704.
DOI: 10.1016/j.apsb.2024.05.015.
Physiological Roles of Eumelanin- and Melanogenesis-Associated Diseases: A Look at the Potentialities of Engineered and Microbial Eumelanin in Clinical Practice.
Terranova M
Bioengineering (Basel). 2024; 11(8).
PMID: 39199714
PMC: 11351163.
DOI: 10.3390/bioengineering11080756.
The Investigation of Hsp90C-Terminal Inhibitors Containing Amide Bioisosteres.
Amatya E, Subramanian C, Long R, McNamara K, Cohen M, Blagg B
ChemMedChem. 2024; 19(24):e202400418.
PMID: 39153203
PMC: 11649481.
DOI: 10.1002/cmdc.202400418.
Shining New Light on Biological Systems: Luminescent Transition Metal Complexes for Bioimaging and Biosensing Applications.
Lee L, Lo K
Chem Rev. 2024; 124(15):8825-9014.
PMID: 39052606
PMC: 11328004.
DOI: 10.1021/acs.chemrev.3c00629.
Genomic analysis reveals the association of KIT and MITF variants with the white spotting in swamp buffaloes.
Dai D, Sari E, Si J, Ashari H, Andi Dagong M, Pauciullo A
BMC Genomics. 2024; 25(1):713.
PMID: 39048931
PMC: 11267946.
DOI: 10.1186/s12864-024-10634-2.
Multiple Endocrine Neoplasia Type 1 Regulates TGFβ-Mediated Suppression of Tumor Formation and Metastasis in Melanoma.
Boudreault J, Canaff L, Ghozlan M, Wang N, Guarnieri V, Salcuni A
Cells. 2024; 13(11.
PMID: 38891107
PMC: 11172218.
DOI: 10.3390/cells13110973.
Primary cervicothoracic melanoma of spinal cord: a case report and literature review.
Dang Y, Du A, Wei W, Xue J
Front Oncol. 2024; 14:1417268.
PMID: 38863638
PMC: 11165122.
DOI: 10.3389/fonc.2024.1417268.
Identification of a metabolism-linked genomic signature for prognosis and immunotherapeutic efficiency in metastatic skin cutaneous melanoma.
He Z, Lyu J, Lyu L, Long X, Xu B
Medicine (Baltimore). 2024; 103(23):e38347.
PMID: 38847706
PMC: 11155616.
DOI: 10.1097/MD.0000000000038347.
Quercetin Induces Mitochondrial Apoptosis and Downregulates Ganglioside GD3 Expression in Melanoma Cells.
Seo S, Ju W, Kim K, Kim J, Yu J, Ryu J
Int J Mol Sci. 2024; 25(10).
PMID: 38791186
PMC: 11121576.
DOI: 10.3390/ijms25105146.
Modeling Melanoma Heterogeneity In Vitro: Redox, Resistance and Pigmentation Profiles.
Carvalho L, Noma I, Uehara A, Siena A, Osaki L, Mori M
Antioxidants (Basel). 2024; 13(5).
PMID: 38790661
PMC: 11118096.
DOI: 10.3390/antiox13050555.